Theodore Wagener, PhD, discusses an Ohio State feasibility study testing psilocybin-assisted therapy for depression in patients with non–small cell lung cancer.
Theodore Wagener, PhD
Advertisement
Articles by Theodore Wagener, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Tucatinib Maintenance Regimen in HER2+ Metastatic Breast Cancer
2
SurVaxM Improves OS Only in Younger Subgroup in Newly Diagnosed Glioblastoma
3
Phase 2 Data Show PFS Benefit With Carotuximab Combo in mCRPC
4
Dr Bazhenova on Taletrectinib Label Update and Subgroup Data in ROS1+ NSCLC
5